Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Movement disorders and psychosis, a complex marriage.

van Harten PN, Bakker PR, Mentzel CL, Tijssen MA, Tenback DE.

Front Psychiatry. 2015 Jan 9;5:190. doi: 10.3389/fpsyt.2014.00190. eCollection 2014. Review. No abstract available.

2.

Off-label antipsychotic use and tardive dyskinesia in at-risk populations: new drugs with old side effects.

Remington G, Hahn M.

J Psychiatry Neurosci. 2014 Jan;39(1):E1-2. doi: 10.1503/jpn.120205. No abstract available.

3.

Tardive dyskinesia: therapeutic options for an increasingly common disorder.

Cloud LJ, Zutshi D, Factor SA.

Neurotherapeutics. 2014 Jan;11(1):166-76. doi: 10.1007/s13311-013-0222-5.

4.

Treatment of neurolept-induced tardive dyskinesia.

Jankelowitz SK.

Neuropsychiatr Dis Treat. 2013;9:1371-80. doi: 10.2147/NDT.S30767. Epub 2013 Sep 16. Review.

5.

The incidence of tardive dyskinesia in the study of pharmacotherapy for psychotic depression.

Blumberger DM, Mulsant BH, Kanellopoulos D, Whyte EM, Rothschild AJ, Flint AJ, Meyers BS.

J Clin Psychopharmacol. 2013 Jun;33(3):391-7. doi: 10.1097/JCP.0b013e31828bf059.

6.

CNS medications as predictors of precipitous cognitive decline in the cognitively disabled aged: a longitudinal population-based study.

Puustinen J, Nurminen J, Vahlberg T, Lyles A, Isoaho R, Räihä I, Kivelä SL.

Dement Geriatr Cogn Dis Extra. 2012 Jan;2(1):57-68. doi: 10.1159/000336710. Epub 2012 Mar 16.

7.

Relevance of animal models to human tardive dyskinesia.

Blanchet PJ, Parent MT, Rompré PH, Lévesque D.

Behav Brain Funct. 2012 Mar 9;8:12. doi: 10.1186/1744-9081-8-12. Review.

8.

Treatment of the special patient with schizophrenia.

Conley RR, Kelly DL.

Dialogues Clin Neurosci. 2001 Jun;3(2):123-35.

9.

Incidence of tardive dyskinesia with risperidone or olanzapine in the elderly: results from a 2-year, prospective study in antipsychotic-naïve patients.

Woerner MG, Correll CU, Alvir JM, Greenwald B, Delman H, Kane JM.

Neuropsychopharmacology. 2011 Jul;36(8):1738-46. doi: 10.1038/npp.2011.55. Epub 2011 Apr 20.

10.

Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study.

Woods SW, Morgenstern H, Saksa JR, Walsh BC, Sullivan MC, Money R, Hawkins KA, Gueorguieva RV, Glazer WM.

J Clin Psychiatry. 2010 Apr;71(4):463-74. doi: 10.4088/JCP.07m03890yel. Epub 2010 Feb 9.

11.

Low dose vs standard dose of antipsychotics for relapse prevention in schizophrenia: meta-analysis.

Uchida H, Suzuki T, Takeuchi H, Arenovich T, Mamo DC.

Schizophr Bull. 2011 Jul;37(4):788-99. doi: 10.1093/schbul/sbp149. Epub 2009 Nov 27.

12.

Recognition and Management of Behavioral Disturbances in Dementia.

Desai AK, Grossberg GT.

Prim Care Companion J Clin Psychiatry. 2001 Jun;3(3):93-109.

13.

Treating Psychotic Symptoms in Elderly Patients.

Targum SD.

Prim Care Companion J Clin Psychiatry. 2001 Aug;3(4):156-163.

Supplemental Content

Support Center